Advertisement
The company will host a conference call and webcast at 7:30 a.m. CentralTime (8:30 a.m. Eastern Time) on Tuesday, July 29, 2008. ev3 management willreview its second quarter operating results and future outlook, followed by aquestion and answer session.
Advertisement
The conference call will be available to interested parties through a liveaudio webcast at http://ir.ev3.net, where it will be archived and accessiblefor approximately 90 days. The live dial-in number for the call is888-679-8033 (U.S.) or 617-213-4846 (International). The participant passcodeis 64950600.
If you do not have access to the Internet and want to listen to an audioreplay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888(International) and enter passcode 10431647. The audio replay will beavailable beginning at 9:30 a.m. Central Time on Tuesday, July 29, 2008 untilTuesday, August 5, 2008.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developinginnovative, breakthrough and clinically proven technologies and solutions forthe treatment of lower extremity vascular and neurovascular diseases. ev3'sproducts are used by endovascular specialists to treat a wide range ofperipheral vascular and neurovascular diseases and disorders. The companyoffers a comprehensive portfolio of treatment options, including the primaryinterventional technologies used today -- peripheral angioplasty balloons,stents, plaque excision systems, embolic protection devices, liquid embolics,embolization coils, thrombectomy catheters and occlusion balloons. Moreinformation about the company and its products can be found athttp://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S.and other countries.
SOURCE ev3 Inc.
